JAMA Network:老年抑郁症患者对艾司西酞普兰反应的功能和结构神经网络特征比较

2022-08-04 网络 网络

淡漠在老年抑郁症患者中普遍存在,与药物治疗的不良反应有关。

淡漠在老年抑郁症患者中普遍存在,与药物治疗的不良反应有关。阐明与淡漠和不良治疗结果相关的大脑网络可以为干预的发展提供信息。该研究的目的是为了评估老年抑郁症患者淡漠的脑网络特征,并识别与抗抑郁药物反应不良相关的脑网络异常。

在2012年7月1日至2019年7月31日期间,在一家老年精神病学门诊进行的艾司西酞普兰单组、开放标签非随机临床试验的二次分析纳入了40名年龄在59-85岁之间的重度抑郁症患者。参与者接受艾司西酞普兰滴定至目标剂量20mg /d,持续12周。主要结果和测量方法进行了基线和治疗后磁共振成像(MRI)、临床和认知评估。

结果共有40名参与者(26名女性[65%];纳入抑郁患者的平均[SD]年龄=70.0 [范围,59-85岁];20名参与者(50%)表现出淡漠。与非淡漠型抑郁被试相比,抑郁和淡漠被试与背外侧前额叶皮层(DLPFC)、运动前皮层、扣带中皮层和中央旁小叶的显著网络种子rsFC较低,与外侧颞皮层和颞极的显著网络种子rsFC较大。与非淡漠组相比,淡漠组的扣带和额枕束的结构连通性较低。

27名参与者完成艾司西酞普兰治疗;16人(59%)达到缓解(hamd得分<10)。下岛叶- dlpfc /扣带中皮层rsFC与症状改善较少相关且非缓解的可能性较高(OR=1.041 [95% CI, 1.003-1.081];P = 0.04),在回归模型中,是基线淡漠和持续抑郁之间的联系的中介。下背前扣带- dlpfc /中央旁rsFC与注意测量的残余认知障碍和执行功能相关。

该研究表明,显著性网络和其他支持目标导向行为的大型网络之间的连接受到干扰,可能会导致淡漠,并可能与老年抑郁症对抗抑郁药物治疗的不良反应有关。

 

参考文献:

Comparison of Functional and Structural Neural Network Features in Older Adults With Depression With vs Without Apathy and Association With Response to Escitalopram Secondary Analysis of a Nonrandomized Clinical Trial. JAMA Network Open. 2022;5(7):e2224142. doi:10.1001/jamanetworkopen.2022.24142

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1734530, encodeId=ea9b1e3453064, content=<a href='/topic/show?id=d4f412668a4' target=_blank style='color:#2F92EE;'>#NET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12668, encryptionId=d4f412668a4, topicName=NET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ea033781210, createdName=canlab, createdTime=Sat Aug 27 17:14:33 CST 2022, time=2022-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1988627, encodeId=ed39198862e40, content=<a href='/topic/show?id=1fe2549e72e' target=_blank style='color:#2F92EE;'>#抑郁症患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54977, encryptionId=1fe2549e72e, topicName=抑郁症患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ce68183, createdName=xiongke010, createdTime=Tue Nov 22 17:14:33 CST 2022, time=2022-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1974012, encodeId=2c6319e401222, content=<a href='/topic/show?id=fb5d801809e' target=_blank style='color:#2F92EE;'>#老年抑郁症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80180, encryptionId=fb5d801809e, topicName=老年抑郁症)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3c932500160, createdName=ms7421025882867189, createdTime=Thu Feb 16 15:14:33 CST 2023, time=2023-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1632515, encodeId=c35e163251567, content=<a href='/topic/show?id=edf586e533d' target=_blank style='color:#2F92EE;'>#艾司西酞普兰#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86753, encryptionId=edf586e533d, topicName=艾司西酞普兰)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c9e521925158, createdName=zhty5344, createdTime=Tue Jun 06 08:14:33 CST 2023, time=2023-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1568395, encodeId=bfde156839534, content=<a href='/topic/show?id=31e090549c1' target=_blank style='color:#2F92EE;'>#西酞普兰#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90549, encryptionId=31e090549c1, topicName=西酞普兰)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4dcf15370486, createdName=wolongzxh, createdTime=Thu Aug 04 01:14:33 CST 2022, time=2022-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1630377, encodeId=81cd16303e739, content=<a href='/topic/show?id=44e0e449217' target=_blank style='color:#2F92EE;'>#神经网络#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74492, encryptionId=44e0e449217, topicName=神经网络)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6ff21497204, createdName=by2016, createdTime=Thu Aug 04 01:14:33 CST 2022, time=2022-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1243627, encodeId=a8c9124362e7e, content=JAMA上文章都是顶级的,谢谢梅斯及时上新, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=肿瘤克星, createdTime=Tue Aug 02 13:14:33 CST 2022, time=2022-08-02, status=1, ipAttribution=)]
    2022-08-27 canlab
  2. [GetPortalCommentsPageByObjectIdResponse(id=1734530, encodeId=ea9b1e3453064, content=<a href='/topic/show?id=d4f412668a4' target=_blank style='color:#2F92EE;'>#NET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12668, encryptionId=d4f412668a4, topicName=NET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ea033781210, createdName=canlab, createdTime=Sat Aug 27 17:14:33 CST 2022, time=2022-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1988627, encodeId=ed39198862e40, content=<a href='/topic/show?id=1fe2549e72e' target=_blank style='color:#2F92EE;'>#抑郁症患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54977, encryptionId=1fe2549e72e, topicName=抑郁症患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ce68183, createdName=xiongke010, createdTime=Tue Nov 22 17:14:33 CST 2022, time=2022-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1974012, encodeId=2c6319e401222, content=<a href='/topic/show?id=fb5d801809e' target=_blank style='color:#2F92EE;'>#老年抑郁症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80180, encryptionId=fb5d801809e, topicName=老年抑郁症)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3c932500160, createdName=ms7421025882867189, createdTime=Thu Feb 16 15:14:33 CST 2023, time=2023-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1632515, encodeId=c35e163251567, content=<a href='/topic/show?id=edf586e533d' target=_blank style='color:#2F92EE;'>#艾司西酞普兰#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86753, encryptionId=edf586e533d, topicName=艾司西酞普兰)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c9e521925158, createdName=zhty5344, createdTime=Tue Jun 06 08:14:33 CST 2023, time=2023-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1568395, encodeId=bfde156839534, content=<a href='/topic/show?id=31e090549c1' target=_blank style='color:#2F92EE;'>#西酞普兰#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90549, encryptionId=31e090549c1, topicName=西酞普兰)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4dcf15370486, createdName=wolongzxh, createdTime=Thu Aug 04 01:14:33 CST 2022, time=2022-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1630377, encodeId=81cd16303e739, content=<a href='/topic/show?id=44e0e449217' target=_blank style='color:#2F92EE;'>#神经网络#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74492, encryptionId=44e0e449217, topicName=神经网络)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6ff21497204, createdName=by2016, createdTime=Thu Aug 04 01:14:33 CST 2022, time=2022-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1243627, encodeId=a8c9124362e7e, content=JAMA上文章都是顶级的,谢谢梅斯及时上新, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=肿瘤克星, createdTime=Tue Aug 02 13:14:33 CST 2022, time=2022-08-02, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1734530, encodeId=ea9b1e3453064, content=<a href='/topic/show?id=d4f412668a4' target=_blank style='color:#2F92EE;'>#NET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12668, encryptionId=d4f412668a4, topicName=NET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ea033781210, createdName=canlab, createdTime=Sat Aug 27 17:14:33 CST 2022, time=2022-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1988627, encodeId=ed39198862e40, content=<a href='/topic/show?id=1fe2549e72e' target=_blank style='color:#2F92EE;'>#抑郁症患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54977, encryptionId=1fe2549e72e, topicName=抑郁症患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ce68183, createdName=xiongke010, createdTime=Tue Nov 22 17:14:33 CST 2022, time=2022-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1974012, encodeId=2c6319e401222, content=<a href='/topic/show?id=fb5d801809e' target=_blank style='color:#2F92EE;'>#老年抑郁症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80180, encryptionId=fb5d801809e, topicName=老年抑郁症)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3c932500160, createdName=ms7421025882867189, createdTime=Thu Feb 16 15:14:33 CST 2023, time=2023-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1632515, encodeId=c35e163251567, content=<a href='/topic/show?id=edf586e533d' target=_blank style='color:#2F92EE;'>#艾司西酞普兰#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86753, encryptionId=edf586e533d, topicName=艾司西酞普兰)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c9e521925158, createdName=zhty5344, createdTime=Tue Jun 06 08:14:33 CST 2023, time=2023-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1568395, encodeId=bfde156839534, content=<a href='/topic/show?id=31e090549c1' target=_blank style='color:#2F92EE;'>#西酞普兰#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90549, encryptionId=31e090549c1, topicName=西酞普兰)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4dcf15370486, createdName=wolongzxh, createdTime=Thu Aug 04 01:14:33 CST 2022, time=2022-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1630377, encodeId=81cd16303e739, content=<a href='/topic/show?id=44e0e449217' target=_blank style='color:#2F92EE;'>#神经网络#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74492, encryptionId=44e0e449217, topicName=神经网络)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6ff21497204, createdName=by2016, createdTime=Thu Aug 04 01:14:33 CST 2022, time=2022-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1243627, encodeId=a8c9124362e7e, content=JAMA上文章都是顶级的,谢谢梅斯及时上新, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=肿瘤克星, createdTime=Tue Aug 02 13:14:33 CST 2022, time=2022-08-02, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1734530, encodeId=ea9b1e3453064, content=<a href='/topic/show?id=d4f412668a4' target=_blank style='color:#2F92EE;'>#NET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12668, encryptionId=d4f412668a4, topicName=NET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ea033781210, createdName=canlab, createdTime=Sat Aug 27 17:14:33 CST 2022, time=2022-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1988627, encodeId=ed39198862e40, content=<a href='/topic/show?id=1fe2549e72e' target=_blank style='color:#2F92EE;'>#抑郁症患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54977, encryptionId=1fe2549e72e, topicName=抑郁症患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ce68183, createdName=xiongke010, createdTime=Tue Nov 22 17:14:33 CST 2022, time=2022-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1974012, encodeId=2c6319e401222, content=<a href='/topic/show?id=fb5d801809e' target=_blank style='color:#2F92EE;'>#老年抑郁症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80180, encryptionId=fb5d801809e, topicName=老年抑郁症)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3c932500160, createdName=ms7421025882867189, createdTime=Thu Feb 16 15:14:33 CST 2023, time=2023-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1632515, encodeId=c35e163251567, content=<a href='/topic/show?id=edf586e533d' target=_blank style='color:#2F92EE;'>#艾司西酞普兰#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86753, encryptionId=edf586e533d, topicName=艾司西酞普兰)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c9e521925158, createdName=zhty5344, createdTime=Tue Jun 06 08:14:33 CST 2023, time=2023-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1568395, encodeId=bfde156839534, content=<a href='/topic/show?id=31e090549c1' target=_blank style='color:#2F92EE;'>#西酞普兰#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90549, encryptionId=31e090549c1, topicName=西酞普兰)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4dcf15370486, createdName=wolongzxh, createdTime=Thu Aug 04 01:14:33 CST 2022, time=2022-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1630377, encodeId=81cd16303e739, content=<a href='/topic/show?id=44e0e449217' target=_blank style='color:#2F92EE;'>#神经网络#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74492, encryptionId=44e0e449217, topicName=神经网络)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6ff21497204, createdName=by2016, createdTime=Thu Aug 04 01:14:33 CST 2022, time=2022-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1243627, encodeId=a8c9124362e7e, content=JAMA上文章都是顶级的,谢谢梅斯及时上新, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=肿瘤克星, createdTime=Tue Aug 02 13:14:33 CST 2022, time=2022-08-02, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1734530, encodeId=ea9b1e3453064, content=<a href='/topic/show?id=d4f412668a4' target=_blank style='color:#2F92EE;'>#NET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12668, encryptionId=d4f412668a4, topicName=NET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ea033781210, createdName=canlab, createdTime=Sat Aug 27 17:14:33 CST 2022, time=2022-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1988627, encodeId=ed39198862e40, content=<a href='/topic/show?id=1fe2549e72e' target=_blank style='color:#2F92EE;'>#抑郁症患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54977, encryptionId=1fe2549e72e, topicName=抑郁症患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ce68183, createdName=xiongke010, createdTime=Tue Nov 22 17:14:33 CST 2022, time=2022-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1974012, encodeId=2c6319e401222, content=<a href='/topic/show?id=fb5d801809e' target=_blank style='color:#2F92EE;'>#老年抑郁症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80180, encryptionId=fb5d801809e, topicName=老年抑郁症)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3c932500160, createdName=ms7421025882867189, createdTime=Thu Feb 16 15:14:33 CST 2023, time=2023-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1632515, encodeId=c35e163251567, content=<a href='/topic/show?id=edf586e533d' target=_blank style='color:#2F92EE;'>#艾司西酞普兰#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86753, encryptionId=edf586e533d, topicName=艾司西酞普兰)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c9e521925158, createdName=zhty5344, createdTime=Tue Jun 06 08:14:33 CST 2023, time=2023-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1568395, encodeId=bfde156839534, content=<a href='/topic/show?id=31e090549c1' target=_blank style='color:#2F92EE;'>#西酞普兰#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90549, encryptionId=31e090549c1, topicName=西酞普兰)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4dcf15370486, createdName=wolongzxh, createdTime=Thu Aug 04 01:14:33 CST 2022, time=2022-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1630377, encodeId=81cd16303e739, content=<a href='/topic/show?id=44e0e449217' target=_blank style='color:#2F92EE;'>#神经网络#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74492, encryptionId=44e0e449217, topicName=神经网络)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6ff21497204, createdName=by2016, createdTime=Thu Aug 04 01:14:33 CST 2022, time=2022-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1243627, encodeId=a8c9124362e7e, content=JAMA上文章都是顶级的,谢谢梅斯及时上新, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=肿瘤克星, createdTime=Tue Aug 02 13:14:33 CST 2022, time=2022-08-02, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=1734530, encodeId=ea9b1e3453064, content=<a href='/topic/show?id=d4f412668a4' target=_blank style='color:#2F92EE;'>#NET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12668, encryptionId=d4f412668a4, topicName=NET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ea033781210, createdName=canlab, createdTime=Sat Aug 27 17:14:33 CST 2022, time=2022-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1988627, encodeId=ed39198862e40, content=<a href='/topic/show?id=1fe2549e72e' target=_blank style='color:#2F92EE;'>#抑郁症患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54977, encryptionId=1fe2549e72e, topicName=抑郁症患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ce68183, createdName=xiongke010, createdTime=Tue Nov 22 17:14:33 CST 2022, time=2022-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1974012, encodeId=2c6319e401222, content=<a href='/topic/show?id=fb5d801809e' target=_blank style='color:#2F92EE;'>#老年抑郁症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80180, encryptionId=fb5d801809e, topicName=老年抑郁症)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3c932500160, createdName=ms7421025882867189, createdTime=Thu Feb 16 15:14:33 CST 2023, time=2023-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1632515, encodeId=c35e163251567, content=<a href='/topic/show?id=edf586e533d' target=_blank style='color:#2F92EE;'>#艾司西酞普兰#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86753, encryptionId=edf586e533d, topicName=艾司西酞普兰)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c9e521925158, createdName=zhty5344, createdTime=Tue Jun 06 08:14:33 CST 2023, time=2023-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1568395, encodeId=bfde156839534, content=<a href='/topic/show?id=31e090549c1' target=_blank style='color:#2F92EE;'>#西酞普兰#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90549, encryptionId=31e090549c1, topicName=西酞普兰)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4dcf15370486, createdName=wolongzxh, createdTime=Thu Aug 04 01:14:33 CST 2022, time=2022-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1630377, encodeId=81cd16303e739, content=<a href='/topic/show?id=44e0e449217' target=_blank style='color:#2F92EE;'>#神经网络#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74492, encryptionId=44e0e449217, topicName=神经网络)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6ff21497204, createdName=by2016, createdTime=Thu Aug 04 01:14:33 CST 2022, time=2022-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1243627, encodeId=a8c9124362e7e, content=JAMA上文章都是顶级的,谢谢梅斯及时上新, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=肿瘤克星, createdTime=Tue Aug 02 13:14:33 CST 2022, time=2022-08-02, status=1, ipAttribution=)]
  7. [GetPortalCommentsPageByObjectIdResponse(id=1734530, encodeId=ea9b1e3453064, content=<a href='/topic/show?id=d4f412668a4' target=_blank style='color:#2F92EE;'>#NET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12668, encryptionId=d4f412668a4, topicName=NET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ea033781210, createdName=canlab, createdTime=Sat Aug 27 17:14:33 CST 2022, time=2022-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1988627, encodeId=ed39198862e40, content=<a href='/topic/show?id=1fe2549e72e' target=_blank style='color:#2F92EE;'>#抑郁症患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54977, encryptionId=1fe2549e72e, topicName=抑郁症患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ce68183, createdName=xiongke010, createdTime=Tue Nov 22 17:14:33 CST 2022, time=2022-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1974012, encodeId=2c6319e401222, content=<a href='/topic/show?id=fb5d801809e' target=_blank style='color:#2F92EE;'>#老年抑郁症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80180, encryptionId=fb5d801809e, topicName=老年抑郁症)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3c932500160, createdName=ms7421025882867189, createdTime=Thu Feb 16 15:14:33 CST 2023, time=2023-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1632515, encodeId=c35e163251567, content=<a href='/topic/show?id=edf586e533d' target=_blank style='color:#2F92EE;'>#艾司西酞普兰#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86753, encryptionId=edf586e533d, topicName=艾司西酞普兰)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c9e521925158, createdName=zhty5344, createdTime=Tue Jun 06 08:14:33 CST 2023, time=2023-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1568395, encodeId=bfde156839534, content=<a href='/topic/show?id=31e090549c1' target=_blank style='color:#2F92EE;'>#西酞普兰#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90549, encryptionId=31e090549c1, topicName=西酞普兰)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4dcf15370486, createdName=wolongzxh, createdTime=Thu Aug 04 01:14:33 CST 2022, time=2022-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1630377, encodeId=81cd16303e739, content=<a href='/topic/show?id=44e0e449217' target=_blank style='color:#2F92EE;'>#神经网络#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74492, encryptionId=44e0e449217, topicName=神经网络)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6ff21497204, createdName=by2016, createdTime=Thu Aug 04 01:14:33 CST 2022, time=2022-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1243627, encodeId=a8c9124362e7e, content=JAMA上文章都是顶级的,谢谢梅斯及时上新, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=肿瘤克星, createdTime=Tue Aug 02 13:14:33 CST 2022, time=2022-08-02, status=1, ipAttribution=)]
    2022-08-02 肿瘤克星

    JAMA上文章都是顶级的,谢谢梅斯及时上新

    0

相关资讯

久坐对身体的伤害远比想象中大!柳叶刀子刊:每天久坐6小时,增加12种慢性疾病风险

柳叶刀子刊:每天久坐时间超过6小时,与12种常见的慢性疾病风险升高有关;但如果将久坐用不同强度的身体活动代替时,可降低因久坐导致的常见慢性病发生,且身体活动强度越大,可预防慢性病的种类越多。

Alzheimer&Dementia:老年痴呆的遗传易感性会增加中年抑郁症风险!

AD的遗传易感性可能是导致中年抑郁症发病机制的因素之一。

JAMA子刊:重度抑郁症和双相情感障碍与大麻使用障碍存在共同的生理机制

研究结果证实了CUD的家族聚集性。患有BP-II的亲属患CUD的风险增加,表明CUD可能与BP-II有共同的基础病症。

JGH: 炎症性肠病和抑郁症之间存在双向关联

炎性肠病又称炎症性肠病(IBD),为累及回肠、直肠、结肠的一种特发性肠道炎症性疾病。临床表现腹泻、腹痛,甚至可有血便。本病包括溃疡性结肠炎(UC)和克罗恩病(CD)。

精彩直播:难治性抑郁高发?原北大六院王向群院长传授诊疗策略!

难治性抑郁“难处理”?听听院长怎么说!

Hum Psychopharmacol:高剂量VitB6可能缓解焦虑和抑郁

一项新的研究表明,服用高剂量维生素 B6 补充剂可能有助于减轻焦虑和抑郁的感觉。 来自英格兰雷丁大学的研究人员David Field 报告说,服用 50 倍于每日推荐剂量的年轻人报告说,一个

拓展阅读

【热点解读】围绝经期抑郁症筛查及管理的最佳证据总结

本研究总结了PMD筛查及管理的最佳证据,将为临床实践提供循证依据。同时卫生保健人员应意识到PMD给患者带来的危害,掌握正确的筛查及管理方法,在临床实践时结合本土化情况形成个性化管理方式,降低PMD的发

JAMA+BMJ:运动对抑郁症的积极影响

研究表明,即使在低于公共卫生推荐的体力活动水平下,也能显著获益于心理健康。该研究首次表明,运动与抑郁症风险之间存在剂量反应关系。

Mol Psychiatry:成人抑郁症患者的压力生活事件模式和五种精神障碍和神经质的多基因评分

这篇文章在遗传上证明了压力源和素质是相互依存的,并且挑战基于生活事件的诊断和亚型(例如,反应性/内源性)。

Psychol Med:机器学习方法优化精准医疗以优化抑郁症治疗

集成机器学习算法在预测七种第二步治疗的缓解状态方面表现出差异分类性能。对于全套预测变量,AUC 值范围为 0.51 至 0.82,具体取决于第二步治疗类型。预测缓解对认知疗法最成功。

Nature:MMP8有望成为应激相关障碍的新型治疗靶点

外周免疫因子可在压力背景下影响中枢神经系统的功能和行为。针对特定靶向外周免疫细胞分泌的MMP8,未来可能会成为应激相关障碍的新型治疗靶点。

Nature:压力大让人抑郁,真正的原因找到了!抑郁症治疗有望迎来新靶点

该研究发现循环髓细胞特异性蛋白酶基质金属蛋白酶8 (MMP8)在MDD患者以及社会心理压力小鼠模型的血清中表达增加。